BE1012725A5 - Methode de renforcement de l'activite antitumorale de medications brutes, composition contenant une medication brute renforcant l'activite antitumorale, methode d'evaluation de l'efficacite antitumorale par traitement de la medication brute, et methode d'evaluation de l'efficacite antitumorale de medications brutes. - Google Patents

Methode de renforcement de l'activite antitumorale de medications brutes, composition contenant une medication brute renforcant l'activite antitumorale, methode d'evaluation de l'efficacite antitumorale par traitement de la medication brute, et methode d'evaluation de l'efficacite antitumorale de medications brutes. Download PDF

Info

Publication number
BE1012725A5
BE1012725A5 BE9900625A BE9900625A BE1012725A5 BE 1012725 A5 BE1012725 A5 BE 1012725A5 BE 9900625 A BE9900625 A BE 9900625A BE 9900625 A BE9900625 A BE 9900625A BE 1012725 A5 BE1012725 A5 BE 1012725A5
Authority
BE
Belgium
Prior art keywords
sep
raw
medication
tumor activity
fermentation
Prior art date
Application number
BE9900625A
Other languages
English (en)
French (fr)
Inventor
Kozo Niwa
Original Assignee
Kozo Niwaniwa Kozo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kozo Niwaniwa Kozo filed Critical Kozo Niwaniwa Kozo
Application granted granted Critical
Publication of BE1012725A5 publication Critical patent/BE1012725A5/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/071—Agaricus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE9900625A 1998-09-17 1999-09-17 Methode de renforcement de l'activite antitumorale de medications brutes, composition contenant une medication brute renforcant l'activite antitumorale, methode d'evaluation de l'efficacite antitumorale par traitement de la medication brute, et methode d'evaluation de l'efficacite antitumorale de medications brutes. BE1012725A5 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26375398 1998-09-17
JP10323374A JP2000159682A (ja) 1998-09-17 1998-11-13 生薬の抗腫瘍活性強化方法、抗腫瘍活性強化生薬含有組成物、生薬処理の抗腫瘍有効性評価方法、および生薬の抗腫瘍有効性評価方法

Publications (1)

Publication Number Publication Date
BE1012725A5 true BE1012725A5 (fr) 2001-02-06

Family

ID=26546176

Family Applications (1)

Application Number Title Priority Date Filing Date
BE9900625A BE1012725A5 (fr) 1998-09-17 1999-09-17 Methode de renforcement de l'activite antitumorale de medications brutes, composition contenant une medication brute renforcant l'activite antitumorale, methode d'evaluation de l'efficacite antitumorale par traitement de la medication brute, et methode d'evaluation de l'efficacite antitumorale de medications brutes.

Country Status (19)

Country Link
JP (1) JP2000159682A (it)
KR (1) KR20000023206A (it)
CN (1) CN1255376A (it)
AU (1) AU4486299A (it)
BE (1) BE1012725A5 (it)
CA (1) CA2282234A1 (it)
DE (1) DE19944695A1 (it)
DK (1) DK199901235A (it)
ES (1) ES2155802B1 (it)
FR (2) FR2783426A1 (it)
GB (2) GB9920710D0 (it)
ID (1) ID23150A (it)
IL (1) IL131722A0 (it)
IS (1) IS5183A (it)
IT (1) IT1307267B1 (it)
NL (2) NL1013049C2 (it)
NO (1) NO994463L (it)
SE (2) SE9903307L (it)
SG (1) SG76631A1 (it)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100391439C (zh) * 2001-04-27 2008-06-04 味之素株式会社 免疫增强剂
WO2002090559A1 (en) * 2001-05-07 2002-11-14 Biohub Co., Ltd. A method for preparing lactic acid fermented solution of mushroom and lactic acid fermented solution of mushroom produced thereby
JP4499979B2 (ja) * 2001-05-21 2010-07-14 コンビ株式会社 病原菌感染抑制用組成物
EP1393738A4 (en) * 2001-06-01 2004-11-17 Ajinomoto Kk MEDICINE AGAINST DIABETES
JP4826696B2 (ja) * 2003-04-07 2011-11-30 ビーエイチエヌ株式会社 血管新生阻害剤
US7977379B2 (en) 2002-05-15 2011-07-12 Bhn Co., Ltd. Method for angiogenesis inhibition or immunostimulation
JP4681801B2 (ja) * 2002-05-15 2011-05-11 ビーエイチエヌ株式会社 血管新生阻害剤およびその製造方法
JP2005089417A (ja) * 2003-09-19 2005-04-07 Noevir Co Ltd 糖尿病予防・治療用組成物
JP4587441B2 (ja) * 2004-02-12 2010-11-24 株式会社クレハ 新規な糖尿病治療剤および食品
US8034386B2 (en) 2004-09-17 2011-10-11 Ssi Co., Ltd. Extract from Agaricus blazei Murill capable of suppressing breast cancer
JP2006273835A (ja) * 2005-03-04 2006-10-12 Michishi Tani 悪性腫瘍治療剤及びそれを含む飲食品
US20120128856A1 (en) * 2009-07-31 2012-05-24 Ming East-West, Llc Maitake mushroom coffee
JPWO2011081024A1 (ja) * 2009-12-29 2013-05-09 株式会社富士見養蜂園 旨味食品及びその製造方法
CN106309511A (zh) * 2016-08-30 2017-01-11 青海民族大学 圆孢蘑菇抑制cdc25酶有效部位及制法和应用
CN106333969A (zh) * 2016-08-30 2017-01-18 青海民族大学 圆孢蘑菇抑制hdac1酶有效部位及制法和应用
WO2019104579A1 (en) * 2017-11-30 2019-06-06 SHIEH, Darbin Method for predicting and modulating susceptibility of cancer cell to programmed cell death
KR102646421B1 (ko) * 2020-12-16 2024-03-12 대한민국 잎새버섯 생리활성성분 및 영양성분의 함량을 증가시키는 방법
KR102602787B1 (ko) * 2020-12-16 2023-11-17 대한민국 꽃송이버섯 생리활성성분 및 영양성분의 함량을 증가시키는 방법
KR102584680B1 (ko) * 2020-12-17 2023-10-06 대한민국 생리활성 및 영양성분이 증가된 표고버섯차 제조방법

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177108A (en) * 1977-03-02 1979-12-04 Tetsuro Ikekawa Process for producing emitanin
DE2842691A1 (de) * 1978-09-30 1980-04-10 Karl Dr Med Theurer Energetische anregung biologischer arzneimittel
DE4226866A1 (de) * 1991-08-14 1993-02-18 Kozo Niwa Pflanzliche zusammensetzung mit niedrigem molekulargewicht

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5276413A (en) * 1975-12-18 1977-06-27 Kureha Chem Ind Co Ltd Production of oncostatic substances
JPS57206618A (en) * 1981-06-12 1982-12-18 Noda Shiyokukin Kogyo Kk Preparation of antitumor substance
JPH02203765A (ja) * 1989-02-02 1990-08-13 Nippon Beet Sugar Mfg Co Ltd 抗腫瘍機能を有する食品及びその製造法
JP2955126B2 (ja) * 1992-06-22 1999-10-04 笑代 丹羽 医薬用油性製剤、食品用油性製剤およびそれらの製造方法
US6015913A (en) * 1996-09-06 2000-01-18 Mars, Incorporated Method for producing fat and/or solids from cocoa beans

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177108A (en) * 1977-03-02 1979-12-04 Tetsuro Ikekawa Process for producing emitanin
DE2842691A1 (de) * 1978-09-30 1980-04-10 Karl Dr Med Theurer Energetische anregung biologischer arzneimittel
DE4226866A1 (de) * 1991-08-14 1993-02-18 Kozo Niwa Pflanzliche zusammensetzung mit niedrigem molekulargewicht

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; KAWAZOE, TAKAYUKI ET AL: "Efficient transformation of ergosterol to vitamin D-2 by ultraviolet ligh irradiation.", XP002141685, retrieved from STN *
DATABASE CHEMABS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; NIWA, YUKIE ET AL: "Tapering effects on glucocorticoids in autoimmune diseases by natural antioxidant and anti-cancer drug treated with infrared ray heating, fermentation and lipophilization", XP002141686, retrieved from STN Database accession no. 128:57229 *
JOURNAL OF THE JAPANESE SOCIETY FOR FOOD SCIENCE AND TECHNOLOGY, (1995) VOL. 42, NO. 4, PP. 262-267. *
NIWA ET AL: "Anti-cancer effect in vitro and clinical efficacy of a cancer therapeutic containing natural herbs (BG-104), exposed to far infrared-ray heating and fermentation process using Aspergillus oryzae", CHEMICAL ABSTRACTS + INDEXES,US,AMERICAN CHEMICAL SOCIETY. COLUMBUS NR. 49737B, vol. 5, no. 121, 1 August 1994 (1994-08-01), XP002029539, ISSN: 0009-2258 *
OYO YAKURI (1997), 54(4), 227-233 *

Also Published As

Publication number Publication date
AU4486299A (en) 2000-03-30
NO994463L (no) 2000-03-20
GB9921387D0 (en) 1999-11-10
ES2155802B1 (es) 2001-12-01
ITTO990784A1 (it) 2001-03-14
NO994463D0 (no) 1999-09-15
GB2341800A (en) 2000-03-29
KR20000023206A (ko) 2000-04-25
NL1013049C2 (nl) 2002-01-11
SE0100195L (sv) 2001-01-24
NL1013049A1 (nl) 2000-03-21
ITTO990784A0 (it) 1999-09-14
FR2788697A1 (fr) 2000-07-28
IT1307267B1 (it) 2001-10-30
SE0100195D0 (sv) 2001-01-24
CA2282234A1 (en) 2000-03-17
ES2155802A1 (es) 2001-05-16
IS5183A (is) 2000-03-17
SG76631A1 (en) 2000-11-21
FR2783426A1 (fr) 2000-03-24
ID23150A (id) 2000-03-23
DE19944695A1 (de) 2000-03-30
SE9903307D0 (sv) 1999-09-16
JP2000159682A (ja) 2000-06-13
GB9920710D0 (en) 1999-11-03
NL1019705A1 (nl) 2002-01-29
DK199901235A (da) 2000-03-18
SE9903307L (sv) 2000-03-18
IL131722A0 (en) 2001-03-19
NL1019705C2 (nl) 2002-03-26
CN1255376A (zh) 2000-06-07

Similar Documents

Publication Publication Date Title
BE1012725A5 (fr) Methode de renforcement de l'activite antitumorale de medications brutes, composition contenant une medication brute renforcant l'activite antitumorale, methode d'evaluation de l'efficacite antitumorale par traitement de la medication brute, et methode d'evaluation de l'efficacite antitumorale de medications brutes.
BE1000842A3 (fr) Composition antioxydante de produits naturels et son procede de production.
EP3054964B1 (fr) Procede d'obtention d'un extrait de plante et compositions associees
WO2001064057A1 (fr) Nouvelles compositions pharmaceutiques ou dietetiques a base de champignons
BE1006911A3 (fr) Composition huileuse et son procede de preparation.
EP3506918B1 (fr) Composition comprenant des extraits de pollens et/ou de pistils, procede de preparation et utilisations associees
FR2805746A1 (fr) Procede d'augmentation d'activite anti-tumorale, composition ayant une activite anti-tumorale et procede d'evaluation d'efficacite anti-tumorale.
FR2977161A1 (fr) Compositions pour le traitement ou la prevention du cancer de la prostate a base d'extrait de graines de brocoli.
EP3288575A1 (fr) Complexe protéomélanique bioassimilable, préparation et utilisations
EP1874137A1 (fr) Composition de spirulines riche en principes actifs, son procédé d'obtention et son utilisation.
FR3132436A1 (fr) Procede d’obtention d’extraits vegetaux comprenant une etape d’autofermentation, compositions comprenant de tels extraits et leurs utilisations cosmetiques
WO1997013521A1 (fr) Composition prophylactique absorbable ayant un effet protecteur contre les ondes electromagnetiques a effet ionisant ou non ionisant
CA3040784A1 (fr) Integration a des produits alimentaires, cosmetique ou pharmaceutique d'extractions de principes bioactifs de champignons
Fatine et al. Evaluation in vitro de l'activité anticandidosique et antioxydante des extraits de Myrte.
BE1027552B1 (fr) Composition du ginseng et son utilisation comme medicament pour le traitement ou la prevention du stress
Cheriot Rôle des produits de la réaction de Maillard dans l'inhibition de l'oxydation enzymatique des phénols et des lipides
FR3143366A1 (fr) Principe actif cosmétique contenant un extrait de Aureobasidium pullulans
FR3153724A3 (fr) Extrait de fruits d’amla et composition nutritionnelle le contenant
FR2836337A1 (fr) Utilisation des polymeres procyanidoliques a titre d'agents inhibuteurs des alpha-amylases et application dans des compositions a visees dietetiques
Bessot Allergènes végétaux non polliniques
BE1026268A1 (fr) Denrée alimentaire hypocholestéromiante

Legal Events

Date Code Title Description
RE Patent lapsed

Effective date: 20080930